Oh dear. This morning Sweden has become the latest European country to suspend use of the AstraZeneca-Oxford University vaccine. It follows reports that some people have suffered blood clots after being given the jab despite AstraZeneca’s data showing there have only been 37 such reports among the 17 million people across Europe who have been given the vaccine.
Yet while some European health ministries across the continent are raising concerns about its effectiveness, others are lambasting AstraZeneca for failing to deliver enough jabs. French Europe minister Clement Beaune appeared on Radio Classique this morning and raised the prospect of the EU actually suing the company over breach of contract. Citing lower-than-expected deliveries, he claimed: ‘Europe is not going to be some sort of cuddly ‘care bear’ that hands over its money and then expects nothing in return.’
It is the latest chapter in the unhappy saga of the European Commission’s procurement and rollout efforts with the Oxford jab.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in